electronic health record dataset (optum ehr) Search Results


dod optum ehr  (Optum Inc)
86
Optum Inc dod optum ehr
Dod Optum Ehr, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/electronic+health+record+dataset+(optum+ehr)/dod+ehr+optum/10__3390_slash_covid4110125-82-19-21
Average 86 stars, based on 1 article reviews
dod optum ehr - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
optum ehr database  (Optum Inc)
86
Optum Inc optum ehr database
Optum Ehr Database, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/electronic+health+record+dataset+(optum+ehr)/database+ehr+optum/pmc12480313-121-6-6
Average 86 stars, based on 1 article reviews
optum ehr database - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
optum ehr  (Optum Inc)
86
Optum Inc optum ehr
Primary analysis using an ITT design for each of the four outcomes. Results are shown within each database, separately for each outcome: ( A ) schizophrenia as the outcome; ( B ) schizoaffective disorder as the outcome; ( C ) major depressive disorder as the outcome; ( D ) bipolar disorder as the outcome. Events occurring in fewer than five patients are reported as ‘<5’ in accordance with data use agreements. Calibrated risk ratios are comparing the risk of the outcome among patients initiating brain-penetrant CCBs with the risk among patients initiating non-brain-penetrant CCBs. IRs are per 1000 person-years. Note that results are presented for all databases regardless of diagnostic status, though meta-analyses only include results that passed relevant diagnostics. BP-CCBs, brain-penetrant calcium channel blockers; <t>EHR,</t> <t>electronic</t> <t>health</t> <t>record;</t> IR, incidence rate; ITT, intent-to-treat; NP-CCBs, non-brain-penetrant calcium channel blockers; SDM, standardised difference of mean.
Optum Ehr, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/electronic+health+record+dataset+(optum+ehr)/ehr+optum/pmc12958888-80-63-63
Average 86 stars, based on 1 article reviews
optum ehr - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
de identified electronic health record data set  (Optum Inc)
86
Optum Inc de identified electronic health record data set
Primary analysis using an ITT design for each of the four outcomes. Results are shown within each database, separately for each outcome: ( A ) schizophrenia as the outcome; ( B ) schizoaffective disorder as the outcome; ( C ) major depressive disorder as the outcome; ( D ) bipolar disorder as the outcome. Events occurring in fewer than five patients are reported as ‘<5’ in accordance with data use agreements. Calibrated risk ratios are comparing the risk of the outcome among patients initiating brain-penetrant CCBs with the risk among patients initiating non-brain-penetrant CCBs. IRs are per 1000 person-years. Note that results are presented for all databases regardless of diagnostic status, though meta-analyses only include results that passed relevant diagnostics. BP-CCBs, brain-penetrant calcium channel blockers; <t>EHR,</t> <t>electronic</t> <t>health</t> <t>record;</t> IR, incidence rate; ITT, intent-to-treat; NP-CCBs, non-brain-penetrant calcium channel blockers; SDM, standardised difference of mean.
De Identified Electronic Health Record Data Set, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/electronic+health+record+dataset+(optum+ehr)/electronic+health+records/pm40830742-13820-41-48
Average 86 stars, based on 1 article reviews
de identified electronic health record data set - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
optum de identified ehr dataset  (Optum Inc)
86
Optum Inc optum de identified ehr dataset
Primary analysis using an ITT design for each of the four outcomes. Results are shown within each database, separately for each outcome: ( A ) schizophrenia as the outcome; ( B ) schizoaffective disorder as the outcome; ( C ) major depressive disorder as the outcome; ( D ) bipolar disorder as the outcome. Events occurring in fewer than five patients are reported as ‘<5’ in accordance with data use agreements. Calibrated risk ratios are comparing the risk of the outcome among patients initiating brain-penetrant CCBs with the risk among patients initiating non-brain-penetrant CCBs. IRs are per 1000 person-years. Note that results are presented for all databases regardless of diagnostic status, though meta-analyses only include results that passed relevant diagnostics. BP-CCBs, brain-penetrant calcium channel blockers; <t>EHR,</t> <t>electronic</t> <t>health</t> <t>record;</t> IR, incidence rate; ITT, intent-to-treat; NP-CCBs, non-brain-penetrant calcium channel blockers; SDM, standardised difference of mean.
Optum De Identified Ehr Dataset, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/electronic+health+record+dataset+(optum+ehr)/database+de+ehr+identified+optum/pm38414540-103-10-10
Average 86 stars, based on 1 article reviews
optum de identified ehr dataset - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
congestive hf  (Optum Inc)
86
Optum Inc congestive hf
Primary analysis using an ITT design for each of the four outcomes. Results are shown within each database, separately for each outcome: ( A ) schizophrenia as the outcome; ( B ) schizoaffective disorder as the outcome; ( C ) major depressive disorder as the outcome; ( D ) bipolar disorder as the outcome. Events occurring in fewer than five patients are reported as ‘<5’ in accordance with data use agreements. Calibrated risk ratios are comparing the risk of the outcome among patients initiating brain-penetrant CCBs with the risk among patients initiating non-brain-penetrant CCBs. IRs are per 1000 person-years. Note that results are presented for all databases regardless of diagnostic status, though meta-analyses only include results that passed relevant diagnostics. BP-CCBs, brain-penetrant calcium channel blockers; <t>EHR,</t> <t>electronic</t> <t>health</t> <t>record;</t> IR, incidence rate; ITT, intent-to-treat; NP-CCBs, non-brain-penetrant calcium channel blockers; SDM, standardised difference of mean.
Congestive Hf, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/electronic+health+record+dataset+(optum+ehr)/congestive+hf/pmc12317948-156-21-30
Average 86 stars, based on 1 article reviews
congestive hf - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
clinical ehr database aggregates longitudinal  (Optum Inc)
86
Optum Inc clinical ehr database aggregates longitudinal
Primary analysis using an ITT design for each of the four outcomes. Results are shown within each database, separately for each outcome: ( A ) schizophrenia as the outcome; ( B ) schizoaffective disorder as the outcome; ( C ) major depressive disorder as the outcome; ( D ) bipolar disorder as the outcome. Events occurring in fewer than five patients are reported as ‘<5’ in accordance with data use agreements. Calibrated risk ratios are comparing the risk of the outcome among patients initiating brain-penetrant CCBs with the risk among patients initiating non-brain-penetrant CCBs. IRs are per 1000 person-years. Note that results are presented for all databases regardless of diagnostic status, though meta-analyses only include results that passed relevant diagnostics. BP-CCBs, brain-penetrant calcium channel blockers; <t>EHR,</t> <t>electronic</t> <t>health</t> <t>record;</t> IR, incidence rate; ITT, intent-to-treat; NP-CCBs, non-brain-penetrant calcium channel blockers; SDM, standardised difference of mean.
Clinical Ehr Database Aggregates Longitudinal, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/electronic+health+record+dataset+(optum+ehr)/clinical+ehr/pm41439382-41-1-0
Average 86 stars, based on 1 article reviews
clinical ehr database aggregates longitudinal - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
sidiap-spain  (IQVIA Inc)
90
IQVIA Inc sidiap-spain
Primary analysis using an ITT design for each of the four outcomes. Results are shown within each database, separately for each outcome: ( A ) schizophrenia as the outcome; ( B ) schizoaffective disorder as the outcome; ( C ) major depressive disorder as the outcome; ( D ) bipolar disorder as the outcome. Events occurring in fewer than five patients are reported as ‘<5’ in accordance with data use agreements. Calibrated risk ratios are comparing the risk of the outcome among patients initiating brain-penetrant CCBs with the risk among patients initiating non-brain-penetrant CCBs. IRs are per 1000 person-years. Note that results are presented for all databases regardless of diagnostic status, though meta-analyses only include results that passed relevant diagnostics. BP-CCBs, brain-penetrant calcium channel blockers; <t>EHR,</t> <t>electronic</t> <t>health</t> <t>record;</t> IR, incidence rate; ITT, intent-to-treat; NP-CCBs, non-brain-penetrant calcium channel blockers; SDM, standardised difference of mean.
Sidiap Spain, supplied by IQVIA Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/electronic+health+record+dataset+(optum+ehr)/sidiap+spain/pm34049958-110-16-20
Average 90 stars, based on 1 article reviews
sidiap-spain - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
ehr data  (Optum Inc)
86
Optum Inc ehr data
Primary analysis using an ITT design for each of the four outcomes. Results are shown within each database, separately for each outcome: ( A ) schizophrenia as the outcome; ( B ) schizoaffective disorder as the outcome; ( C ) major depressive disorder as the outcome; ( D ) bipolar disorder as the outcome. Events occurring in fewer than five patients are reported as ‘<5’ in accordance with data use agreements. Calibrated risk ratios are comparing the risk of the outcome among patients initiating brain-penetrant CCBs with the risk among patients initiating non-brain-penetrant CCBs. IRs are per 1000 person-years. Note that results are presented for all databases regardless of diagnostic status, though meta-analyses only include results that passed relevant diagnostics. BP-CCBs, brain-penetrant calcium channel blockers; <t>EHR,</t> <t>electronic</t> <t>health</t> <t>record;</t> IR, incidence rate; ITT, intent-to-treat; NP-CCBs, non-brain-penetrant calcium channel blockers; SDM, standardised difference of mean.
Ehr Data, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/electronic+health+record+dataset+(optum+ehr)/clinformatics+data+database+mart/pm40983262-199-22-24
Average 86 stars, based on 1 article reviews
ehr data - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
ehr dataset  (Humedica Inc)
90
Humedica Inc ehr dataset
Primary analysis using an ITT design for each of the four outcomes. Results are shown within each database, separately for each outcome: ( A ) schizophrenia as the outcome; ( B ) schizoaffective disorder as the outcome; ( C ) major depressive disorder as the outcome; ( D ) bipolar disorder as the outcome. Events occurring in fewer than five patients are reported as ‘<5’ in accordance with data use agreements. Calibrated risk ratios are comparing the risk of the outcome among patients initiating brain-penetrant CCBs with the risk among patients initiating non-brain-penetrant CCBs. IRs are per 1000 person-years. Note that results are presented for all databases regardless of diagnostic status, though meta-analyses only include results that passed relevant diagnostics. BP-CCBs, brain-penetrant calcium channel blockers; <t>EHR,</t> <t>electronic</t> <t>health</t> <t>record;</t> IR, incidence rate; ITT, intent-to-treat; NP-CCBs, non-brain-penetrant calcium channel blockers; SDM, standardised difference of mean.
Ehr Dataset, supplied by Humedica Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/electronic+health+record+dataset+(optum+ehr)/ehr+dataset/10__1016_slash_j__jval__2017__05__005-57-1-1
Average 90 stars, based on 1 article reviews
ehr dataset - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
optum ehr  (Humedica Inc)
90
Humedica Inc optum ehr
Summary of studies on natural language processing (NLP) and hypoglycemia.
Optum Ehr, supplied by Humedica Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/electronic+health+record+dataset+(optum+ehr)/optum+ehr/pmc09152713-8-10-10
Average 90 stars, based on 1 article reviews
optum ehr - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
optum oncology ehr data  (Optum Inc)
86
Optum Inc optum oncology ehr data
Summary of studies on natural language processing (NLP) and hypoglycemia.
Optum Oncology Ehr Data, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/electronic+health+record+dataset+(optum+ehr)/data+ehr+oncology+optum/pmc11444596-54-10-10
Average 86 stars, based on 1 article reviews
optum oncology ehr data - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


Primary analysis using an ITT design for each of the four outcomes. Results are shown within each database, separately for each outcome: ( A ) schizophrenia as the outcome; ( B ) schizoaffective disorder as the outcome; ( C ) major depressive disorder as the outcome; ( D ) bipolar disorder as the outcome. Events occurring in fewer than five patients are reported as ‘<5’ in accordance with data use agreements. Calibrated risk ratios are comparing the risk of the outcome among patients initiating brain-penetrant CCBs with the risk among patients initiating non-brain-penetrant CCBs. IRs are per 1000 person-years. Note that results are presented for all databases regardless of diagnostic status, though meta-analyses only include results that passed relevant diagnostics. BP-CCBs, brain-penetrant calcium channel blockers; EHR, electronic health record; IR, incidence rate; ITT, intent-to-treat; NP-CCBs, non-brain-penetrant calcium channel blockers; SDM, standardised difference of mean.

Journal: BMJ Open

Article Title: Lack of association between the brain penetrance of calcium channel blockers and the incidence of neuropsychiatric outcomes: a retrospective, multidatabase cohort study

doi: 10.1136/bmjopen-2025-100282

Figure Lengend Snippet: Primary analysis using an ITT design for each of the four outcomes. Results are shown within each database, separately for each outcome: ( A ) schizophrenia as the outcome; ( B ) schizoaffective disorder as the outcome; ( C ) major depressive disorder as the outcome; ( D ) bipolar disorder as the outcome. Events occurring in fewer than five patients are reported as ‘<5’ in accordance with data use agreements. Calibrated risk ratios are comparing the risk of the outcome among patients initiating brain-penetrant CCBs with the risk among patients initiating non-brain-penetrant CCBs. IRs are per 1000 person-years. Note that results are presented for all databases regardless of diagnostic status, though meta-analyses only include results that passed relevant diagnostics. BP-CCBs, brain-penetrant calcium channel blockers; EHR, electronic health record; IR, incidence rate; ITT, intent-to-treat; NP-CCBs, non-brain-penetrant calcium channel blockers; SDM, standardised difference of mean.

Article Snippet: Databases included the (1) Merative MarketScan Commercial Database (CCAE), (2) Merative MarketScan Multi-State Medicaid Database (MDCD), (3) Merative MarketScan Medicare Supplemental Database (MDCR), (4) Optum Clinformatics Data Mart (Optum Clinformatics), (5) The IQVIA Adjudicated Health Plan Claims Data (PharMetrics Plus), (6) IQVIA Disease Analyzer Germany (IQVIA Germany), (7) Japanese Claims Data (JMDC), (8) IQVIA longitudinal patient data in Australia (IQVIA Australia) and (9) Optum EHR.

Techniques: Diagnostic Assay

Secondary analysis, requiring at least 180 days of continuous exposure, at-risk period starting at day 180. Results are shown within each database, separately for each outcome: ( A ) schizophrenia as the outcome; ( B ) schizoaffective disorder as the outcome; ( C ) major depressive disorder as the outcome; ( D ) bipolar disorder as the outcome. Events occurring in fewer than five patients are reported as ‘<5’ in accordance with data use agreements. Note that results are presented for all databases regardless of diagnostic status, though meta-analyses only include results that passed relevant diagnostics. BP CCBs, brain-penetrant calcium channel blockers; EHR, electronic health record; IR, incidence rate (per 1000 person-years); NP-CCBs, non-brain penetrant calcium channel blockers; SDM, standardised difference of mean.

Journal: BMJ Open

Article Title: Lack of association between the brain penetrance of calcium channel blockers and the incidence of neuropsychiatric outcomes: a retrospective, multidatabase cohort study

doi: 10.1136/bmjopen-2025-100282

Figure Lengend Snippet: Secondary analysis, requiring at least 180 days of continuous exposure, at-risk period starting at day 180. Results are shown within each database, separately for each outcome: ( A ) schizophrenia as the outcome; ( B ) schizoaffective disorder as the outcome; ( C ) major depressive disorder as the outcome; ( D ) bipolar disorder as the outcome. Events occurring in fewer than five patients are reported as ‘<5’ in accordance with data use agreements. Note that results are presented for all databases regardless of diagnostic status, though meta-analyses only include results that passed relevant diagnostics. BP CCBs, brain-penetrant calcium channel blockers; EHR, electronic health record; IR, incidence rate (per 1000 person-years); NP-CCBs, non-brain penetrant calcium channel blockers; SDM, standardised difference of mean.

Article Snippet: Databases included the (1) Merative MarketScan Commercial Database (CCAE), (2) Merative MarketScan Multi-State Medicaid Database (MDCD), (3) Merative MarketScan Medicare Supplemental Database (MDCR), (4) Optum Clinformatics Data Mart (Optum Clinformatics), (5) The IQVIA Adjudicated Health Plan Claims Data (PharMetrics Plus), (6) IQVIA Disease Analyzer Germany (IQVIA Germany), (7) Japanese Claims Data (JMDC), (8) IQVIA longitudinal patient data in Australia (IQVIA Australia) and (9) Optum EHR.

Techniques: Diagnostic Assay

Summary of studies on natural language processing (NLP) and hypoglycemia.

Journal: JMIR Diabetes

Article Title: Identifying Patients With Hypoglycemia Using Natural Language Processing: Systematic Literature Review

doi: 10.2196/34681

Figure Lengend Snippet: Summary of studies on natural language processing (NLP) and hypoglycemia.

Article Snippet: Nunes et al, 2016 [ ], United States , Optum Humedica EHR a database, which incorporates EHRs from 35 large medical provider organizations (including >195 hospitals), >25,000 physicians, and >25 million patients, making up the largest EHR database within the United States (January 2009 to March 2014) , Serious: ICD-9 b identified events were characterized as serious or nonserious if the diagnosis was identified within a problem list; NLP-identified categories included serious (eg, serious, acute, severe, and profound); mild to moderate: NLP-identified categories included mild to moderate (eg, mild, moderate, slight, and minor) , ICD-9 algorithm (structured diagnostic codes only); NLP algorithm (NLP of clinical notes); combined algorithm (either ICD-9 diagnostic codes or NLP of clinical notes) , Rule-based , The final algorithm was validated by manual review: precision (PPV c )=0.77, recall (sensitivity)=0.67 , Period prevalence (%): any conditions: ICD-9: 12.37, NLP: 25.11, combined: 32.19; serious: ICD-9: 11.93, NLP: 10.71, combined: 18.72; mild to moderate: ICD-9: 0.00, NLP: 0.76, combined: 0.78. Incidence rate (per 100 person-years): any conditions: ICD-9: 2.25, NLP: 4.78, combined: 6.28. Serious: ICD-9: 2.12, NLP: 1.72, combined: 3.19; mild to moderate: ICD-9: 0.00, NLP: 0.09, combined: 0.08. Event rate (per 100 person-years): any conditions: ICD-9: 6.92, NLP: 10.03, combined: 16.12; serious: ICD-9: 6.63, NLP: 3.06, combined: 8.90; mild to moderate: ICD-9: 0.00, NLP: 0.20, combined: 0.19.

Techniques: Diagnostic Assay, Modification, Generated